11 – 20 of 39
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Intensity of factor VIII treatment and the development of inhibitors in non-severe hemophilia A patients : Results of the INSIGHT case-control study
- Contribution to journal › Article
- 2016
-
Mark
Aspects of prophylactic treatment of hemophilia
- Contribution to journal › Scientific review
-
Mark
Does the intensity and quality of treatment and not only the factor VIII level influence global hemostasis in patients with hemophilia A?
- Contribution to journal › Letter
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
- Contribution to journal › Article
- 2014
-
Mark
The Fc gamma receptor IIa R131H polymorphism is associated with inhibitor development in severe hemophilia A
- Contribution to journal › Article
-
Mark
Factor VIII therapy for hemophilia A: current and future issues
- Contribution to journal › Scientific review
- 2013
-
Mark
Exploring Anti-FVIII Antibodies in Haemophilia A - Role in In Vitro Haemostasis and Clinical Disease
- Thesis › Doctoral thesis (compilation)
- 2012
-
Mark
Origin of Swedish hemophilia A mutations
- Contribution to journal › Article
-
Mark
Optimizing joint function : new knowledge and novel tools and treatments
- Contribution to journal › Article
- 2009
-
Mark
Impact of polymorphisms of the major histocompatibility complex class II, interleukin-10, tumor necrosis factor-alpha and cytotoxic T-lymphocyte antigen-4 genes on inhibitor development in severe hemophilia A
- Contribution to journal › Article
